Nexien Biopharma, Inc.

Drug Manufacturers - Specialty & Generic • Healthcare • Glendale, CO, United States • NXEN (PNK)

Nexien BioPharma, Inc. focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders, and medical conditions in the United States. The company was formerly known as Intiva BioPharma Inc. and changed its name to Nexien BioPharma, Inc. in September 2018. Nexien BioPharma, Inc. is based in Glendale, Colorado.

303 495 7583 4340 East Kentucky Avenue, Glendale, CO 80246, United States

Stock Performance (90 Days)

Data through Dec 26, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Cannabinoids in pharma series: the future prospects of cannabinoids - European Pharmaceutical Review

European Pharmaceutical Review • Aug 27

Cannabinoids in pharma series: cannabinoids on the market today - European Pharmaceutical Review

European Pharmaceutical Review • Aug 15

Cannabinoids in pharma series: the challenges of working with cannabinoids - European Pharmaceutical Review

European Pharmaceutical Review • Aug 20

Other Drug Manufacturers - Specialty & Generic Companies

View All →

Elanco Animal Health Inc.

Takeda Pharmaceutical Co. Ltd.

$47.02B market cap

Haleon PLC

$44.93B market cap

TEVA Pharmaceutical Industries Ltd.

$32.82B market cap

Frequently Asked Questions

Has NEXIEN BIOPHARMA, INC. had layoffs?

No layoff events have been recorded for NEXIEN BIOPHARMA, INC. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

What industry is NEXIEN BIOPHARMA, INC. in?

NEXIEN BIOPHARMA, INC. operates in the Drug Manufacturers - Specialty & Generic industry, within the Healthcare sector.

Is NEXIEN BIOPHARMA, INC. a publicly traded company?

Yes, NEXIEN BIOPHARMA, INC. is publicly traded under the ticker symbol NXEN on the PNK. The company has a market capitalization of approximately $0.00 billion.

Where is NEXIEN BIOPHARMA, INC. headquartered?

NEXIEN BIOPHARMA, INC. is headquartered in Glendale, CO, United States at 4340 East Kentucky Avenue, Glendale, CO 80246, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.